z-logo
open-access-imgOpen Access
Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson’s Disease Patients
Author(s) -
Jingyuan Yang,
LI Xiao-hu,
Renmin Yang,
Xuen Yu,
Chunshui Yu,
Yinfeng Qian,
Yu Yan
Publication year - 2015
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0125100
Subject(s) - putamen , globus pallidus , caudate nucleus , substantia nigra , susceptibility weighted imaging , red nucleus , wilson's disease , medicine , magnetic resonance imaging , thalamus , basal ganglia , 5 ht4 receptor , pathology , nuclear magnetic resonance , nuclear medicine , parkinson's disease , nucleus , radiology , central nervous system , disease , psychiatry , physics , receptor , serotonin
Purpose It is well known that patients with Wilson’s disease (WD) suffer copper metabolism disorder. However, recent studies point to an additional iron metabolism disorder in WD patients. The purpose of our study was to examine susceptibility-weighted imaging (SWI) manifestations of WD in the brains of WD patients. Methods A total of 33 patients with WD and 18 normal controls underwent conventional MRI (Magnetic resonance imaging) and SWI. The phase values were measured on SWI-filtered phase images of the bilateral head of the caudate nuclei, globus pallidus, putamen, thalamus, substantia nigra, and red nucleus. Student’s t -tests were used to compare the phase values between WD groups and normal controls. Results The mean phase values for the bilateral head of the caudate nuclei, globus pallidus, putamen, thalamus, substantia nigra, and red nucleus were significantly lower than those in the control group (P < 0.001), and bilateral putamen was most strongly affected. Conclusions There is paramagnetic mineralization deposition in brain gray nuclei of WD patients and SWI is an effective method to evaluate these structures.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here